Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 12 Trial at 2023 American Society of Clinical Oncology Annual Meeting - Yahoo Finance
| PRRUF Stock | USD 0.20 0.00 0.00% |
Roughly 61% of Immutep's investor base is looking to short. The analysis of overall sentiment of trading Immutep Limited pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Immutep's historical and current headlines, can help investors time the market. In addition, many technical investors use Immutep Limited stock news signals to limit their universe of possible portfolio assets.
Immutep pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Immutep daily returns and investor perception about the current price of Immutep Limited as well as its diversification or hedging effects on your existing portfolios.
Immutep |
Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 12 Trial at 2023 American Society of Clinical Oncology Annual Meeting Yahoo Finance
Read at news.google.com
 |
Immutep Fundamental Analysis
We analyze Immutep's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immutep using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immutep based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Immutep is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Immutep Limited Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immutep pink sheet to make a market-neutral strategy. Peer analysis of Immutep could also be used in its relative valuation, which is a method of valuing Immutep by comparing valuation metrics with similar companies.
Peers
Immutep Related Equities
| ENVB | Enveric Biosciences | 9.09 | ||||
| SLN | Silence Therapeutics | 2.33 | ||||
| AADI | Aadi Bioscience | 0.41 | ||||
| CDTX | Cidara Therapeutics | 0.82 | ||||
| CYTK | Cytokinetics | 0.91 | ||||
| CGEM | Cullinan Oncology | 2.56 | ||||
| CTMX | CytomX Therapeutics | 5.08 | ||||
| VRDN | Viridian Therapeutics | 5.22 | ||||
| ALXO | Alx Oncology | 5.96 | ||||
| ELEV | Elevation Oncology | 6.94 | ||||
| GPCR | Structure Therapeutics | 7.42 | ||||
| CRNX | Crinetics Pharmaceuticals | 7.53 | ||||
| APLT | Applied Therapeutics | 8.06 | ||||
| IMMX | Immix Biopharma | 8.19 | ||||
| ALVR | Allovir | 9.80 | ||||
| ZNTL | Zentalis Pharmaceuticals | 10.57 | ||||
| ADCT | ADC Therapeutics | 10.81 | ||||
| DSGN | Design Therapeutics | 11.01 | ||||
| ZURA | Zura Bio | 12.35 | ||||
| SANA | Sana Biotechnology | 12.82 | ||||
| OLMA | Olema Pharmaceuticals | 20.10 |
Complementary Tools for Immutep Pink Sheet analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |